UBP
DGX icon

Union Bancaire Privee’s Quest Diagnostics DGX Stock Holding History

Union Bancaire Privee’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Sell
380
-7,267
-95% -$1.43M ﹤0.01% 432
2026
Q1 		$1.24M Sell
7,647
-1,097
-13% -$213K 0.02% 277
2025
Q4 		$1.22M Buy
+8,744
New +$1.59M 0.01% 276

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Union Bancaire Privee's DGX Position: Q2 2026 in Review

Union Bancaire Privee reduced its Quest Diagnostics (DGX) stake by 95% in Q2 2026, selling an estimated $1.43M and leaving 380 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Union Bancaire Privee first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.24M in Q1 2026. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Union Bancaire Privee held 380 shares of Quest Diagnostics worth $61K as of Q2 2026.
  • Union Bancaire Privee sold 7,267 Quest Diagnostics shares in Q2 2026, an estimated $1.43M.
  • Quest Diagnostics made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #432 holding.
  • Union Bancaire Privee first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • Union Bancaire Privee's Quest Diagnostics position peaked at $1.24M in Q1 2026.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.